MIAMI, March 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation ...
The CAGLA NeauxCancer Conference is a premier gathering of leading oncology researchers, industry executives, investors and medical professionals focused on groundbreaking developments in cancer ...
Pasithea Therapeutics Corp. announced that its Vice President of Business Development, Mathew Lazarus, will present at the 2025 Cancer Advocacy Group of Louisiana (CAGLA) NeauxCancer Conference from ...
Theriva Biologics, a clinical-stage company focused on developing cancer therapeutics, announced its participation in the NeauxCancer 2025 Conference hosted by the Cancer Advocacy Group of Louisiana ...
SAN JOSE, Calif., March 17, 2025 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results